CD34 and acute lymphoblastic leukemia: Rather, AML and ALL samples had a significantly greater proportion of the genome that was marked by H3K27me3 than CD34+ cells (Fig. 2j and Extended Data Fig. 7e), suggesting that these tumor types are more differentiated.